Introduction: A reliable method of intradialysis calcium mass balance quantification is far from been established. We herein investigated the use of a single-pool variable-volume Calcium kinetic model to assess calcium mass balance in chronic and stable dialysis patients.
plasma water calcium concentration is a deviation on our main hypothesis, meaning that a substantial amount of calcium is exchanged between the extracellular volume and a nonmodeled compartment.
INTRODUCTION
Management of calcium metabolism in CKD-5D patients is of paramount importance. Although this is a muchdebated topics, little is known with certainty and most of the recent guidelines 1 are based on experts' opinions. Notably the debate on the optimal concentration of calcium in the dialysate (d [Ca] ) 2, 3 is still open. The optimal d [Ca] should prevent severe secondary hyperparathyroidism (SHPT), as well as cardiovascular and soft tissue calcifications. Some authors support the use of a low d [Ca] to reduce the long-term risk of vascular and valvular calcification 4, 5 while others suggest avoiding low d [Ca] , because it may favor hypotension, cardiac arrhythmias during hemodialysis (HD) as well as worsen SHPT. 6 Thus, from the clinical point of view, it is crucial to assess calcium balance during each HD session to tailor the intradialysis balance to the patient needs.
Few incongruent studies yielding conflicting results on intradialytic calcium mass balance (CaMB) have been published and little is known on intradialysis CaMB management. In the context of the DialysIS study (Dialysis therapy between Italy and Switzerland, aimed to improve the personalization of hemodialytic treatments through a modellistic approach), we evaluated the intradialysis CaMB by applying a Single-Pool Variable-Volume Calcium Kinetic Model (SPVV-CaKM) to patients on chronic HD. 7 Specifically, we investigated the SPVV-CaKM accuracy in predicting the serum calcium at the end of dialysis session. The differences between our proposal and the model suggested by Gotch et al. 7 are a different set of parameters (Donnan's factor and calcium effective ionic dialysance) and instead of a theoretic approach, the use of real clinical data derived by implementing the model in dialysis patients. The aim of our study is to provide a simple and precise instrument capable of giving an accurate estimate of intradialytic calcium mass balance in a clinical setting.
RESULTS

Patients' data
Thirty-four patients (20 males and 14 females, mean age 71.6 6 9.7 years, vintage 71.0 6 55.4 months) on thriceweekly HD were studied during 240 sessions (mean 6.5 6 1.9 for each patient; range 3-9). All patients were dialysed with a nominal d[Ca] of 1.50 mmol/L; the prescribed blood flow rate (Qbi) ranged between 150 to 350 mL/minutes, dialysate flow rate (Qdi) was fixed to 500 mL/minutes and the treatment time ranged from 3 to 5 hours (Figure 1 (Figure 1 ).
Model's results
The end dialysis calcium concentration in the plasma water (Ca 21 pwtP) was accurately estimated by the singlecompartment variable-volume calcium kinetic model (SPVV-CaKM) illustrated in 7 : 0.14 6 0.07 vs. 0.06 6 0.07 mmol/L; P < 0.001) and smaller convective (from patient to dialysate) calcium flux. The opposite was true in case of negative Ca 21 MB. We interpreted the difference between predicted and measured end-dialysis ionized plasma water calcium concentration as an error in the main hypothesis. So, if the predicted plasma water ionized calcium concentration is different from the measured value, it means that there is an exchange of calcium from the extracellular compartment toward a nonmodeled compartment. We defined this exchange as sequestration or mobilization (MCa
21
, mmol), as in. 7 As expected, a significant sequestration of Ca 21 from extracellular fluid compartment (MCa 21 ) was noted in Group 2 (0.69 6 0.31 mmol vs. 0.08 6 0.31 mmol, P < 0.001, in Group 2 and 1, respectively).
Finally, we verified whether bone remodelling, as estimated by PTH values, could affect Ca 21 MB. 8 Patients were divided into two groups according to PTH levels less than two times the upper values of normality (130 pg/mL) or more than nine times the upper values of normality (585 pg/mL). Eleven patients showed PTH levels > 585 pg/mL; 6 patients showed PTH levels < 130 pg/mL; 3 patients exhibited a reduction from high to normal levels during cinacalcet treatment (Table 2) .
DISCUSSION
The optimal d[Ca] choice has important implications in preventing or at least reducing renal bone disease, cardiovascular calcifications and intradialytic arrhythmias and hypotensions in HD patients. However, how to manipulate the intradialysis calcium balance to achieve these results is still an unanswered question.
Very few incongruent studies on intradialysis CaMB have been published so far. [8] [9] [10] [11] The inconsistencies found in these studies can be explained by the chosen method of CaMB estimation. All of these studies quantified CaMB collecting the total effluent dialysate to measure total calcium concentration. With this procedure, even a low imprecision in the analytical method to assess [Ca] might induce a substantial CaMB calculation error. Total calcium is most frequently measured using spectrophotometry and the o-cresolphthalein complexone dye. According to a within-run per cent coefficient of variation of 2.5, the maximum standard deviation with ] solubility. 12 Hence, ionized calcium based methods 11 may overestimate CaMB if pH-mediated variation in ionized calcium concentration are not appropriately accounted.
The inconsistences found in these papers led us to raise some questions about the proposed methodological approach and to choose a modellistic solution, based on the one previously described by Gotch, 7 capable of overcome these difficulties. In this study, intradialysis Ca 21 MB was determined by a single-compartment variablevolume kinetic model enabling calculation of Ca 21 content in the extracellular fluid compartment from the start to the end of each dialysis session. Prerequisites to use this method are the accurate estimation of the Donnan coefficient (a factor) and of the "effective" calcium dialysance. The a factor, we used in our study was obtained by the ratio between ultrafiltrate and inlet blood stream ionized calcium concentrations with ultrafiltrate values normalized at pH 7.40, because ultrafiltrate ionized calcium values are also pH dependent. 13 We derived the "effective" calcium dialysance from the conductivity dialysance obtained from the DiascanV R module (Baxter Gambro Dasco Spa, Medolla MO). The mean value of repeated conductivity dialysances using a singlestep conductivity profile, as DiascanV R does, may be considered an adequate estimate of urea clearance corrected for total recirculation. 14 We considered the calcium dialysance similar to the urea dialysance, given the similar molecular weight of urea and calcium. These are considered small molecules (<200 u), thus having similar diffusive proprieties, without considering electric charge. The dialyzer mass transfer coefficient per area may be considered similar between the two compounds and the difference between the two dialysance can be considered expression of the different effective flows (blood water for urea and plasma water for calcium).
Most of our patient using a nominal dialysate [Ca] of 1.50 mmol/L showed a neglectable difference between measured and predicted end-dialysis plasma water ionized calcium concentration suggesting that the model is accurate, it allows a dialysis calcium mass balance estimation and it may guide individualized d[Ca] prescription.
The fact that Ca 21 pwt(P-M) was, in some patients, significantly different from zero (P < 0.001) suggests the existence of a calcium flux from the extracellular compartment to a not modeled pool. In particular, three patients who experienced dialysis sessions with Ca 21 pwt(P-M) 0.05 mmol/L and later on experienced dialysis sessions with Ca 21 pwt(P-M) > 0.05 mmol/L. A post hoc review of patients' chart revealed that in all three patients this phenomenon occurred when treatment with cinacalcet was started, suggesting that our method may be able to catch the effect of treatment on calcium balance during dialysis. Of course, this intriguing hypothesis needs confirmation in a larger specifically designed study. The actual distribution volume of calcium during dialysis is not known, but several authors 7, [15] [16] [17] pointed out that, when the different compartment involved in calcium metabolism are in dynamic-equilibrium, the extracellular volume could be a fair approximation of the distribution volume of calcium. The good agreement between the end dialysis Ca 21 concentration predicted by the model and the measured value support this hypothesis under certain conditions.
Since a precise measurement of the rapidly exchangeable Ca pool and the other compartments that may be involved in calcium kinetics cannot be made in a simple and direct manner during the clinical routine, adding to the SPVV-CaKM compartments that cannot be modeled can only lead to imprecision and confusion. From this particular vantage point, a single-pool model represents an acceptable simplification, with a high degree of accuracy and ready-to-use when the underlying hypothesis are confirmed. In the minority of studied patients, in which our model predictions were significantly different from collected data, other compartments may come into play, but it is still an open question, outside the scope of the present study, whether and how different factors may contribute to modify the equilibrium between all the compartments possibly involved in calcium homeostasis.
We observed a significant decrease in PTH plasma levels in all the patients regardless of the Ca mass balance (negative in 76% patients and positive in the remaining 24%) supporting the hypothesis that parathyroid glands respond primarily to the increase in Ca 21 pw secondary to the diffusive flux from the dialysate to the patient as it was the case in our population. We could not find any significant relationship between PTH levels outside the suggested target range (2-9 times the upper reference limit for the assay) 1 and global, diffusive, or convective Ca 21 MB, possibly due to the low number of patients with (Table 2) . A decreased diffusive Ca 21 MB may account for the negative to positive Ca 21 MB transition observed in patients that initiated cinacalcet in the course of the study recordings since this drug modify the calcium/PTH set point and increases the blood-dialysate calcium gradient. Our results also suggest that factors such as sodium dialysate profiling commonly used in daily practice may substantially change the "nominal" concentration of calcium in dialysate. This observation may contribute to explain the apparent discrepancy of our results with previous ones since the real calcium concentration is often lower than the "nominal" calcium concertation reported in the dialysate bags.
At the present time, there is not a consensus on the proper management of calcium in CKD-5D patients, mostly because the pathogenesis and progression of many mineral-related disorders (e.g., coronary calcifications, calcific uremic arteriopathy) are not completely understood. The presented kinetic model is a valid instrument when dealing with this complex and multifaceted problem and it has several advantage on the calcium mass balance performed with total or partial dialysate collection, namely the ease of use in routine clinical practice, the ability to predict the end dialysis plasma water calcium concentration when different calcium concentrations in the dialysate are used and the prediction of calcium that will not appear in the extracellular volume (MCa 21 ), with the risk of calcium complexes deposition. In Figure 4 , we propose a practical use of the SPVV-CaKM in clinical routine, without presumption of completeness. If these results will be confirmed by other large studies a nomogram-like approach may also be feasible for a routine evaluation of Ca 21 MB. This instrument may also provide a common basis for classifying the patients: as the model takes in considerations several parameters to estimate calcium balance, classifying patients based on the estimated balance could avoid important confounders and thus improve accuracy and reliability of calcium homeostasis studies in CKD-5D patients.
The main limitations of this study are the relatively small sample size and the fact that all study subjects received dialysis with a nominal calcium concentration of 1.50 mmol/L in the dialysate. The presented model is based on several hypotheses, many of them are difficult to prove rigorously, and it needs further validation, including a dedicated study comparing the model's performance with different calcium dialysate concentrations (1.25, 1.50, and 1.75 mmol/L) and use of drugs that interfere with bone metabolism (e.g., cinacalcet). However, the rigorous methodology and the wide range of ionized calcium concentrations in the dialysate utilized are in our opinion the strengths of current findings. In conclusions, current results suggest that it is feasible to estimate the intradialysis global calcium balance using a singlecompartment variable-volume calcium kinetic model (SPVV-CaKM). Furthermore, this study shows that using a fixed nominal dialysate calcium concentration (1.50 mmol/ L), Ca 21 MB can vary widely not only between patients but even in the same patient, according to its pharmacological treatment. Our data corroborates the notion that global Ca 21 MB depends not only on d[Ca] but also on predialysis plasma water calcium [Ca 2 1 pw0] total ultrafiltration and bone metabolism. Therefore, it is unlikely that one dialysate calcium concentrations may be adequate for all the patients. This is particularly true considering the great variability in the patient drug prescription for serum PTH, calcium, and phosphate management. An integrated approach that encompasses all these factors is needed for a personalized d [Ca] prescription. In this view, the presented model offer to the practising nephrologists an accurate view of what is going on during dialysis, such as convective removal, diffusive exchanges and quantity of calcium that will not appear in the extracellular fluid, thus possibly improving the management of calcium metabolism in CKD-5D patients.
MATERIALS AND METHODS
Experimental design
All patients, after signing the informed consent form, have been monitored for a minimum of 3 dialysis sessions. During each monitored session, several parameters has been recorded: Dialysis' duration and total ultrafiltration Blood samples for the evaluation of ionized plasma water calcium and sodium concentrations, pH, urea, albumin, and PTH concentrations both at the start and at the end of the treatment. The end-dialysis sample has been acquired after reduction of blood flow to 50 mL/minutes for 3 minutes Dialysate sample for the determination of ionized calcium and sodium concentrations, collected from the prefilter dialysate port thirty minutes after session's start Conductivity Dialysance and blood flow values through the entire session
Calcium modeling
The main hypothesis of the adopted model is that the calcium distribution volume is equal to extracellular volume, which means that, at least during dialysis treatment, there is no net exchange between the extracellular volume and other compartments.
Intradialysis Ca 21 MB was defined as the change in Ca 21 content in the extracellular fluid volume during a dialysis session and calculated according to Equation 2 reported in the Appendix.
All dialysis sessions were performed with Gambro Artis TM machine equipped with DiascanV R module for automatic determination of "effective" conductivity dialysance that is conductivity dialysance corrected for cardiopulmonary and access recirculation (D 0 cond ).
14 End-dialysis urea distribution volume (V U t) was determined using D 
